Literature DB >> 2206792

Changes in indocyanine green kinetics after the administration of enalapril to healthy subjects.

J Geneve1, T Le Dinh, A Brouard, M Bails, J M Segrestaa, C Caulin.   

Abstract

Enalapril maleate, an angiotensin converting enzyme inhibitor, is a vasodilator liable to modify regional blood flow. The effects of an oral dose of 40 mg enalapril maleate on indocyanine green (ICG) kinetics were assessed in nine healthy subjects. At 4 h after the administration of the drug, a 35% decrease in ICG clearance was observed (P less than 0.01) associated with a 23% decrease in its volume of distribution (P less than 0.02). The half-life of ICG was not altered significantly by enalapril. These results suggest that the administration of enalapril maleate to healthy subjects may reduce apparent liver plasma flow and plasma volume, as a consequence of the pooling of blood in the hepatosplanchnic area.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2206792      PMCID: PMC1368232          DOI: 10.1111/j.1365-2125.1990.tb03779.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure.

Authors:  M A Creager; J L Halperin; D B Bernard; D P Faxon; C D Melidossian; H Gavras; T J Ryan
Journal:  Circulation       Date:  1981-09       Impact factor: 29.690

3.  Angiotensin-converting enzyme in diseases of the liver.

Authors:  K Matsuki; T Sakata
Journal:  Am J Med       Date:  1982-10       Impact factor: 4.965

4.  Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis.

Authors:  J Bosch; V Arroyo; A Betriu; A Mas; F Carrilho; F Rivera; F Navarro-Lopez; J Rodes
Journal:  Gastroenterology       Date:  1980-01       Impact factor: 22.682

5.  Effects of captopril on hepatic venous pressure and blood flow in patients with liver cirrhosis.

Authors:  L S Eriksson; B Kågedal; J Wahren
Journal:  Am J Med       Date:  1984-05-31       Impact factor: 4.965

6.  Changes in cerebral blood flow in patients with severe congestive cardiac failure before and after captopril treatment.

Authors:  B Rajagopalan; A E Raine; R Cooper; J G Ledingham
Journal:  Am J Med       Date:  1984-05-31       Impact factor: 4.965

7.  Effects of converting enzyme inhibitor on hepatic blood flow in man.

Authors:  I R Crossley; D Bihari; A E Gimson; D Westaby; P J Richardson; R Williams
Journal:  Am J Med       Date:  1984-05-31       Impact factor: 4.965

8.  Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521.

Authors:  J A Millar; F H Derkx; K McLean; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

9.  The influence of captopril, the nitrates and propranolol on apparent liver blood flow.

Authors:  A N Shepherd; P C Hayes; M Jacyna; L Morrison; I A Bouchier
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

Review 10.  Enalapril: a review of human pharmacology.

Authors:  H J Gomez; V J Cirillo; J D Irvin
Journal:  Drugs       Date:  1985       Impact factor: 9.546

View more
  4 in total

1.  The feasibility of real-time in vivo optical detection of blood-brain barrier disruption with indocyanine green.

Authors:  Aysegul Ergin; Mei Wang; Jane Y Zhang; Jeffrey N Bruce; Robert L Fine; Irving J Bigio; Shailendra Joshi
Journal:  J Neurooncol       Date:  2011-10-01       Impact factor: 4.130

2.  Dynamic contrast-enhanced near-infrared spectroscopy using indocyanine green on moderate and severe traumatic brain injury: a prospective observational study.

Authors:  Mario Forcione; Kamal Makram Yakoub; Antonio Maria Chiarelli; David Perpetuini; Arcangelo Merla; Rosa Sun; Piotr Sawosz; Antonio Belli; David James Davies
Journal:  Quant Imaging Med Surg       Date:  2020-11

3.  The influence of nifedipine and captopril on liver blood flow in healthy subjects.

Authors:  J Burggraaf; R C Schoemaker; J M Kroon; A F Cohen
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

4.  Fluid distribution kinetics during cardiopulmonary bypass.

Authors:  Mattias Törnudd; Robert G Hahn; Joachim H Zdolsek
Journal:  Clinics (Sao Paulo)       Date:  2014-08       Impact factor: 2.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.